Literature DB >> 29436731

A controversy on the role of short-chain fatty acids in the pathogenesis of Parkinson's disease.

Agata Mulak1.   

Abstract

Entities:  

Keywords:  Parkinson's disease; brain-gut axis; gut microbiota; short-chain fatty acids

Mesh:

Substances:

Year:  2018        PMID: 29436731     DOI: 10.1002/mds.27304

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


× No keyword cloud information.
  13 in total

Review 1.  Diet and the Microbiota-Gut-Brain Axis: Sowing the Seeds of Good Mental Health.

Authors:  Kirsten Berding; Klara Vlckova; Wolfgang Marx; Harriet Schellekens; Catherine Stanton; Gerard Clarke; Felice Jacka; Timothy G Dinan; John F Cryan
Journal:  Adv Nutr       Date:  2021-07-30       Impact factor: 8.701

2.  Fecal Calprotectin as a Marker of the Gut Immune System Activation Is Elevated in Parkinson's Disease.

Authors:  Agata Mulak; Magdalena Koszewicz; Magdalena Panek-Jeziorna; Ewa Koziorowska-Gawron; Sławomir Budrewicz
Journal:  Front Neurosci       Date:  2019-09-27       Impact factor: 4.677

Review 3.  LRRK2 at the Interface Between Peripheral and Central Immune Function in Parkinson's.

Authors:  Rebecca L Wallings; Mary K Herrick; Malú Gámez Tansey
Journal:  Front Neurosci       Date:  2020-05-21       Impact factor: 4.677

Review 4.  Functional roles of the microbiota-gut-brain axis in Alzheimer's disease: Implications of gut microbiota-targeted therapy.

Authors:  Si-Ran Zhong; Qi Kuang; Fan Zhang; Ben Chen; Zhen-Guo Zhong
Journal:  Transl Neurosci       Date:  2021-12-28       Impact factor: 1.757

Review 5.  Intestinal Inflammation and Parkinson's Disease.

Authors:  Yu Li; Yuanyuan Chen; Lili Jiang; Jingyu Zhang; Xuhui Tong; Dapeng Chen; Weidong Le
Journal:  Aging Dis       Date:  2021-12-01       Impact factor: 6.745

Review 6.  Microbiota-targeted interventions for mental health.

Authors:  Kirsten Berding; John F Cryan
Journal:  Curr Opin Psychiatry       Date:  2022-01-01       Impact factor: 4.741

7.  Association of Fecal and Plasma Levels of Short-Chain Fatty Acids With Gut Microbiota and Clinical Severity in Patients With Parkinson Disease.

Authors:  Szu-Ju Chen; Chieh-Chang Chen; Hsin-Yu Liao; Ya-Ting Lin; Yu-Wei Wu; Jyh-Ming Liou; Ming-Shiang Wu; Ching-Hua Kuo; Chin-Hsien Lin
Journal:  Neurology       Date:  2022-01-07       Impact factor: 11.800

8.  Serum short-chain fatty acids and its correlation with motor and non-motor symptoms in Parkinson's disease patients.

Authors:  Gang Wu; Zhengli Jiang; Yaling Pu; Shiyong Chen; Tingling Wang; Yajing Wang; Xiaoping Xu; Shanshan Wang; Minya Jin; Yangyang Yao; Yang Liu; Shaofa Ke; Suzhi Liu
Journal:  BMC Neurol       Date:  2022-01-07       Impact factor: 2.474

9.  Propionic Acid and Fasudil as Treatment Against Rotenone Toxicity in an In Vitro Model of Parkinson's Disease.

Authors:  Friederike Ostendorf; Judith Metzdorf; Ralf Gold; Aiden Haghikia; Lars Tönges
Journal:  Molecules       Date:  2020-05-28       Impact factor: 4.411

Review 10.  New Avenues for Parkinson's Disease Therapeutics: Disease-Modifying Strategies Based on the Gut Microbiota.

Authors:  Marina Lorente-Picón; Ariadna Laguna
Journal:  Biomolecules       Date:  2021-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.